Spironolactone Tablets Recalled Due to Potential Labeling Error
Bryant Ranch Prepack is recalling 35 bottles of Spironolactone 25 mg tablets because they may contain 50 mg tablets.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric.
Plain-English summary
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals is recalling 35 bottles of Spironolactone Tablets, USP, 25 mg. The recall is due to a labeling error where bottles labeled as 25 mg may actually contain 50 mg tablets.
The affected product is manufactured by Frontida BioPharm, Inc. and repackaged by Bryant Ranch Prepack, Inc. The recall covers 30-count, 60-count, and 90-count bottles distributed nationwide in the USA. Specific lot numbers and expiration dates are listed in the recall documentation.
Consumers should check their medication bottles for the specific NDC and lot numbers associated with this recall. If the product matches the description, they should stop using it and contact their healthcare provider or pharmacist for guidance on next steps.
The recalled product
- Product
- Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch…
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 35
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- a) Lot #: 148969
- Exp 7/31/2022
- b) Lot #: 148791
- c) Lot #: 148991
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
See all →- LowButalbital, APAP, Caffeine Tablets Missing Schedule III Label
FDA (Drugs) · 2021-12-01
- LowButalbital/APAP/Caf Tablets Missing Controlled Substance Label
FDA (Drugs) · 2021-12-01
- SevereMethocarbamol Tablets Mislabeled with Incorrect Strength
FDA (Drugs) · 2021-11-10
- ModerateSpironolactone Tablets Recalled Due to Potential Labeling Mix-Up
FDA (Drugs) · 2021-03-24
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- HighSpironolactone 25 mg tablets recalled after aluminum was found in product
FDA (Drugs) · 2025-08-13
- LowButalbital/APAP/Caf Tablets Missing Controlled Substance Label
FDA (Drugs) · 2021-12-01
- SevereMethocarbamol Tablets Mislabeled with Incorrect Strength
FDA (Drugs) · 2021-11-10
- LowButalbital, APAP, Caffeine Tablets Missing Schedule III Label
FDA (Drugs) · 2021-12-01
- LowCephalexin Oral Suspension Recalled for Incorrect Labeling and Missing Dosage Information
FDA (Drugs) · 2024-06-12
- ModerateBryant Ranch Recalls Venlafaxine Tablets Due to Labeling Error
FDA (Drugs) · 2016-05-11